Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 7 Neoplasms 3 Melanoma 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Obesity 2 Infertility 2 Glioblastoma 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 TP53 Y220C Mutation 1 Sarcoma, Ewing 1 Sarcoma 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Posterior Fossa Ependymal Tumor 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms by Site 1 Metabolic Diseases 1 Medulloblastoma 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

Cyclophosphamide 8 fludarabine 6 cabozantinib 5 Temozolomide 4 Doxorubicin 4 Zoledronic Acid 3 X-Rays 3 Vincristine 3 Methotrexate 3 Ifosfamide 3 Gemcitabine 3 Cisplatin 3 irinotecan sucrosofate 2 atezolizumab 2 Surgical Procedures, Operative 2 Sunitinib 2 Specimen Handling 2 Radiosurgery 2 Phantoms, Imaging 2 Mesna 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Eflornithine 2 Disulfiram 2 Biopsy 2 vactosertib 1 trilaciclib 1 trametinib 1 talazoparib 1 surufatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Osteosarcoma × Metformin × Clear all

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡